Michael Burgess News
-
Mark Moy came to the U.S. from China, paid his way through medical school at the University of Illinois in the 1970s and became an emergency room physician.
-
Republicans in the U.S. House adopted a provision designed to save traditional incandescent light bulbs by blocking what one lawmaker called the “energy police” from enforcing an efficiency standard.
-
The Department of Energy would continue to be barred from enforcing new energy efficiency standards for incandescent light bulbs under a planned House amendment that pits bulb manufacturers against the tea party movement.
-
Pfizer Inc. and Merck & Co. are being pulled into an expanding congressional investigation about the agreement drugmakers reached with the Obama administration to support the Democrats’ overhaul of the U.S. health-care system, according to three people familiar with the talks.
-
April Hauge, a nurse practitioner in Weimar, California, spent $500 on a genetic test for her autistic son in 2009 that led to purchasing thousands of dollars in vitamins and supplements. Impressed with the results, she’s now selling advice on the approach to others.
-
The Federal Communications Commission said it initially approved Philip Falcone’s LightSquared Inc. without knowing the wireless service would interfere with global positioning system signals, because GPS- gear makers didn’t complain.
-
Repurchase agreements are set to be excluded from a proposed European Union financial transaction tax, an EU official said.
-
BP Plc Chief Executive Officer Tony Hayward was denounced by U.S. lawmakers for stonewalling as he failed to answer questions about the causes of the oil well explosion in the Gulf of Mexico.
-
BP Plc Chief Executive Officer Tony Hayward was denounced by U.S. lawmakers for stonewalling as he failed to answer questions about the causes of the oil well explosion in the Gulf of Mexico.
-
Teva Pharmaceutical Industries Ltd. failed to win U.S. clearance for the first over-the-counter emergency contraceptive after an Obama Cabinet member overruled the head of the Food and Drug Administration on the issue.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page